“When Wellbe came along it was like a slam dunk, it was a very easy to maneuver platform. We knew the patients were going to love it – it was colorful, it was bright, and it worked on mobile. It gave us the ability to share our CarePath with patients and we knew we were going to be able to collect the PROMs as well.”
“Wellbe has made us more efficient at providing care across the board. Since bringing it live, we’ve seen lower reoperation rates, shorter lengths of stay, readmission rates well below the national average, and fewer patients in secondary nursing facilities. One hundred percent of our patients went home last month.”
“If we were doing things any other way, we wouldn’t have been able to keep up with our standards and quality over the past couple of years.”
The epitome of an entrepreneur, Mark has seen the peaks and valleys of starting, operating, and assuming the risks of a new venture. He’s come up against payroll, had a few bad hires, and even swept the floors early on. Collectively, Mark’s companies have done over $360 million in sales and raised more than $38 million in venture capital, and he has successfully bought and/or sold eight companies.
James believes technology, when creatively applied, can improve our life experiences. Intrigued by the amazing potential for internet and mobile technology to engage us all, James created a business model to reshape personal health management.
Mike Splinter, an electrical engineer and innovator, has played a major role in driving advances in the high tech industry, with more than four decades of executive leadership experience including 12 years with Applied Materials, Inc. where he was served as chairman and CEO, and over 20 years with Intel, where he was executive vice president of sales and marketing, and executive vice president of the Technology and Manufacturing Group.
Mr. Baldwin was most recently Chairman and CEO of Baxa Corporation, a leader in devices, systems, and software for the handling, packaging, and tracking of fluid medications in a critical care setting. Under his leadership from 1997 until its sale to Baxter Corporation in 2011, the company sales grew from $25 million to over $170 million. As CEO, he led the eight-member board of directors and led a minority recap resulting in Goldman Sach’s private equity group owning 27% of the company. He was also an early investor and lead director in Pharmacy OneSource, an innovative software-as-a-service business that had a successful exit in 2010.